Overview

Study Evaluating 3 New Formulations of SKI-606 in Healthy Adult Subjects

Status:
Completed

Trial end date:
2007-09-01

Target enrollment:

Participant gender:

Summary

To evaluate the comparative bioavailability of 3 new tablet formulations of SKI-606 with a reference capsule and an oral solution in healthy subjects.

Phase:

Phase 1

Details

Lead Sponsor:

Wyeth is now a wholly owned subsidiary of Pfizer